Wed Sep 25 07:14:57 UTC 2024: ## Aveanna Healthcare Sees Increased Institutional Interest Amidst Analyst Divergence

**New York, NY (September 25, 2024)** – Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) is attracting growing interest from institutional investors, with several prominent funds boosting their holdings in the home healthcare provider.

Bank of New York Mellon Corp increased its stake by 6.6% in the second quarter, now owning 0.08% of the company, valued at $413,000. Other notable increases came from Acadian Asset Management LLC, Vanguard Group Inc., King Street Capital Management L.P., Littlejohn & Co. LLC, and Nut Tree Capital Management LP. Collectively, institutional investors and hedge funds now own 87.96% of Aveanna Healthcare’s outstanding shares.

This surge in institutional interest comes as analysts offer mixed opinions on the company’s future prospects. While Royal Bank of Canada, Deutsche Bank Aktiengesellschaft, and UBS Group all raised their price targets on Aveanna Healthcare stock, they have differing views on the company’s overall performance. Royal Bank of Canada and Deutsche Bank gave the stock a “sector perform” and “buy” rating respectively, while UBS maintained a “sell” rating.

Aveanna Healthcare recently reported strong quarterly earnings, beating analysts’ expectations. The company achieved revenue of $504.96 million, surpassing estimates of $494.02 million, and reported an EPS of ($0.01) compared to anticipated losses of ($0.04).

Aveanna Healthcare, a diversified home care platform company, specializes in providing pediatric and adult healthcare services throughout the United States. Its patient-centered model focuses on delivering care in patients’ homes, aiming to minimize high-cost hospital and skilled nursing facility utilization.

The company’s stock opened at $5.59 on Wednesday, with a 52-week low of $0.85 and a 52-week high of $5.95. Aveanna Healthcare has a market cap of $1.08 billion, a P/E ratio of -9.32, and a beta of 2.13.

Despite analysts’ differing opinions, the increasing institutional investment in Aveanna Healthcare suggests confidence in the company’s long-term growth potential within the burgeoning home healthcare sector.

Read More